In therapeutic hypothermia, should the patient be given an anticonvulsant, cold intravenous saline, neuroprotective agents, or a dopamine infusion?

Therapeutic Hypothermia Protocol: Core Interventions

Do NOT routinely administer cold intravenous fluids during therapeutic hypothermia, particularly in the prehospital setting, as this practice has been shown to increase complications without improving outcomes. 1, 2

Cold Intravenous Fluids: NOT Recommended

The evidence is clear and consistent against the routine use of cold saline infusions:

• Multiple randomized controlled trials demonstrate no benefit from prehospital or early cold fluid administration for survival or neurological outcomes 2
• Significant harm documented: One major trial found increased rates of pulmonary edema and re-arrest after ROSC when 2L of cold fluids were rapidly infused 1, 2
• Grade 2− recommendation (French guidelines) and Class III: No Benefit (AHA guidelines) explicitly advise against this practice 1, 2

The rationale is straightforward: while cold fluids can lower temperature, the rapid volume loading causes hemodynamic complications that outweigh any theoretical benefit from faster cooling. The target temperature range of 32-36°C should be achieved through surface cooling methods instead 1.

Anticonvulsants: Use Only for Seizure Treatment

Anticonvulsants are not part of the standard therapeutic hypothermia protocol unless seizures are clinically present or confirmed on EEG. The evidence does not support prophylactic anticonvulsant use during TTM. However:

• Seizures are common in post-cardiac arrest patients and neonates with hypoxic-ischemic encephalopathy
• When seizures occur during hypothermia, they should be treated aggressively as they may worsen neurological outcomes
• Be aware that opioids used for sedation during hypothermia have been associated with adverse short-term outcomes including prolonged hospitalization and increased need for vasopressors 3

Neuroprotective Agents: Investigational Only

There are currently no FDA-approved neuroprotective agents recommended as standard adjuncts to therapeutic hypothermia. While research suggests potential synergistic effects with agents like xenon, N-acetylcysteine, erythropoietin, melatonin, and cannabinoids 4, these remain investigational and should not be used outside of clinical trials.

Dopamine Infusion: For Hemodynamic Support Only

Dopamine is not a component of the therapeutic hypothermia protocol itself, but rather a supportive medication for specific complications:

When to Use Dopamine During TTM:

• Hypotension refractory to fluid resuscitation (after appropriate volume expansion to CVP 10-15 cm H₂O or PCWP 14-18 mm Hg) 5
• Increased intracranial pressure in specific cases (e.g., brainstem lesions with elevated ICP) 6

Critical Caveats About Dopamine in Hypothermia:

Dopamine pharmacokinetics are severely altered during deep hypothermia 7:

• At 25°C, dopamine half-life doubles (from 5.4 to 11.6 minutes)
• Plasma concentrations increase 4-fold at the same infusion rate
• Paradoxical effects occur: At 25°C, dopamine increases heart rate but decreases stroke volume by 43%, failing to improve cardiac output
• Effects normalize during rewarming at 30-34°C 7

Dosing Considerations:

• Start at 2-5 mcg/kg/min for modest hemodynamic support 5
• Titrate carefully in 5-10 mcg/kg/min increments
• Monitor closely for arrhythmias, excessive vasoconstriction, and decreased urine output
• Use lower doses during deep hypothermia due to altered pharmacokinetics 7

Standard TTM Protocol Components

The actual therapeutic hypothermia protocol should include:

1. Target temperature: 32-36°C maintained for at least 24 hours 1, 2
2. Cooling method: Surface cooling devices (NOT cold fluid boluses)
3. Temperature monitoring: Continuous core temperature measurement
4. Controlled rewarming: Gradual (avoid rapid rewarming)
5. Fever prevention: Aggressive management of hyperthermia post-rewarming 2

Key Pitfalls to Avoid

• Do not use cold fluid boluses - this is explicitly contraindicated 1, 2
• Do not assume dopamine works the same way during deep hypothermia - it may worsen hemodynamics at temperatures <30°C 7
• Do not prophylactically use anticonvulsants - treat seizures when they occur
• Do not use investigational neuroprotective agents outside research protocols
• Monitor for complications: electrolyte disturbances, arrhythmias, coagulopathy, and infection during the 24+ hour cooling period 8